Kellanova's Q4 2024 results showed a decrease in reported net sales due to adverse currency translation, but organic net sales increased by 7%. Reported operating profit increased significantly, driven by favorable mark-to-market impacts and improved gross profit margin. Earnings per share also saw a substantial increase.
Net sales were negatively impacted by adverse currency translation, but organic-basis growth was above its long-term target range.
Double-digit operating profit growth was sustained due to improved profit margins.
Double-digit growth momentum was sustained in earnings per share, owing primarily to higher operating profit.
Kellanova sustained better-than-expected top-line growth amidst challenging industry conditions.
Due to the pending merger with Mars, Incorporated, Kellanova will not be providing forward looking guidance.
Visualization of income flow from segment revenue to net income